Yuyu Pharma Inc Asset Resilience Ratio
Yuyu Pharma Inc asset resilience ratio. Yuyu Pharma Inc (000227) has an Asset Resilience Ratio of 1.74% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Yuyu Pharma Inc to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Yuyu Pharma Inc (2014–2024)
Asset resilience ratio of Yuyu Pharma Inc from 2014 to 2024. This chart shows how Yuyu Pharma Inc's Asset Resilience Ratio has changed over time. Read Yuyu Pharma Inc (000227) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Yuyu Pharma Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Yuyu Pharma Inc asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.65 Billion | 1.74% |
| Total Liquid Assets | ₩3.65 Billion | 1.74% |
Asset Resilience Insights
- Limited Liquidity: Yuyu Pharma Inc maintains only 1.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Yuyu Pharma Inc Industry Peers by Asset Resilience Ratio
Compare Yuyu Pharma Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Yuyu Pharma Inc Asset Resilience Ratio by Year (2014–2024)
Yuyu Pharma Inc asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Yuyu Pharma Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.39% | ₩817.27 Million ≈ $553.85K |
₩207.69 Billion ≈ $140.75 Million |
-0.49pp |
| 2023-12-31 | 0.88% | ₩1.75 Billion ≈ $1.19 Million |
₩198.21 Billion ≈ $134.33 Million |
-1.65pp |
| 2022-12-31 | 2.53% | ₩4.94 Billion ≈ $3.35 Million |
₩195.21 Billion ≈ $132.29 Million |
+2.41pp |
| 2020-12-31 | 0.12% | ₩180.00 Million ≈ $121.98K |
₩154.90 Billion ≈ $104.97 Million |
-0.29pp |
| 2018-12-31 | 0.40% | ₩545.95 Million ≈ $369.98K |
₩135.23 Billion ≈ $91.64 Million |
-0.01pp |
| 2017-12-31 | 0.41% | ₩500.00 Million ≈ $338.84K |
₩121.49 Billion ≈ $82.33 Million |
-0.05pp |
| 2016-12-31 | 0.46% | ₩509.59 Million ≈ $345.34K |
₩111.30 Billion ≈ $75.43 Million |
-0.02pp |
| 2015-12-31 | 0.48% | ₩500.00 Million ≈ $338.84K |
₩104.33 Billion ≈ $70.70 Million |
-0.06pp |
| 2014-12-31 | 0.54% | ₩550.00 Million ≈ $372.73K |
₩101.40 Billion ≈ $68.72 Million |
-- |
About Yuyu Pharma Inc
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc.… Read more